177 related articles for article (PubMed ID: 20935448)
1. Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome.
Sarac F; Basoglu OK; Gunduz C; Bayrak H; Biray Avci C; Akcicek F
J Endocrinol Invest; 2011; 34(7):528-33. PubMed ID: 20935448
[TBL] [Abstract][Full Text] [Related]
2. [Metabolic profile in obese patients with obstructive sleep apnea. A comparison between patients with insulin resistance and with insulin sensitivity].
Dumitrache-Rujinski S; Dinu I; Călcăianu G; Erhan I; Cocieru A; Zaharia D; Toma CL; Bogdan MA
Pneumologia; 2014; 63(2):100-2, 104-6. PubMed ID: 25241557
[TBL] [Abstract][Full Text] [Related]
3. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome.
Kanbay A; Kokturk O; Ciftci TU; Tavil Y; Bukan N
Respiration; 2008; 76(3):324-30. PubMed ID: 18487876
[TBL] [Abstract][Full Text] [Related]
4. [Lower grade chronic inflammation is associated with obstructive sleep apnea syndrome in type 2 diabetes mellitus].
Zhu H; Wang Z; Xue X; Zhang P; Yang C; Su B
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):411-5. PubMed ID: 25200039
[TBL] [Abstract][Full Text] [Related]
5. [Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome].
Yao SM; Zhang XL
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Sep; 31(9):664-9. PubMed ID: 19080566
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role?
Steiropoulos P; Papanas N; Nena E; Antoniadou M; Serasli E; Papoti S; Hatzizisi O; Kyriazis G; Tzouvelekis A; Maltezos E; Tsara V; Bouros D
Mediators Inflamm; 2010; 2010():675320. PubMed ID: 20628509
[TBL] [Abstract][Full Text] [Related]
7. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.
Makino S; Handa H; Suzukawa K; Fujiwara M; Nakamura M; Muraoka S; Takasago I; Tanaka Y; Hashimoto K; Sugimoto T
Clin Endocrinol (Oxf); 2006 Jan; 64(1):12-9. PubMed ID: 16402923
[TBL] [Abstract][Full Text] [Related]
8. Plasma visfatin levels in severe obstructive sleep apnea-hypopnea syndrome.
Trakada G; Steiropoulos P; Nena E; Gkioka T; Kouliatsis G; Pataka A; Sotiriou I; Anevlavis S; Papanas N; Bouros D
Sleep Breath; 2009 Nov; 13(4):349-55. PubMed ID: 19360446
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.
Ciftci TU; Kokturk O; Bukan N; Bilgihan A
Cytokine; 2004 Oct; 28(2):87-91. PubMed ID: 15381186
[TBL] [Abstract][Full Text] [Related]
10. Independent association of vitamin D and insulin resistance in obstructive sleep apnea.
Fan Z; Cao B; Long H; Feng L; Li Q; Zhang Y; Li T
Ann Endocrinol (Paris); 2019 Nov; 80(5-6):319-323. PubMed ID: 31759518
[TBL] [Abstract][Full Text] [Related]
11. Disorders of glucose metabolism and insulin resistance in patients with obstructive sleep apnoea syndrome.
Bulcun E; Ekici M; Ekici A
Int J Clin Pract; 2012 Jan; 66(1):91-7. PubMed ID: 22171909
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome.
Basoglu OK; Sarac F; Sarac S; Uluer H; Yilmaz C
Ann Thorac Med; 2011 Jul; 6(3):120-5. PubMed ID: 21760842
[TBL] [Abstract][Full Text] [Related]
13. Changes in ghrelin, leptin and pro-inflammatory cytokines after therapy in Obstructive Sleep Apnea Syndrome (OSAS) patients.
De Santis S; Cambi J; Tatti P; Bellussi L; Passali D
Otolaryngol Pol; 2015; 69(2):1-8. PubMed ID: 26224223
[TBL] [Abstract][Full Text] [Related]
14. Metabolic alterations in adolescents with obstructive sleep apnea.
Bhushan B; Ayub B; Loghmanee DA; Billings KR
Int J Pediatr Otorhinolaryngol; 2015 Dec; 79(12):2368-73. PubMed ID: 26581829
[TBL] [Abstract][Full Text] [Related]
15. Obstructive sleep apnea and obesity are associated with reduced GPR 120 plasma levels in children.
Gozal D; Kheirandish-Gozal L; Carreras A; Khalyfa A; Peris E
Sleep; 2014 May; 37(5):935-41. PubMed ID: 24790272
[TBL] [Abstract][Full Text] [Related]
16. Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome.
Archontogeorgis K; Papanas N; Rizos EC; Nena E; Zissimopoulos A; Tsigalou C; Voulgaris A; Mikhailidis DP; Elisaf MS; Froudarakis ME; Steiropoulos P
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31137600
[No Abstract] [Full Text] [Related]
17. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study.
Alberti A; Sarchielli P; Gallinella E; Floridi A; Floridi A; Mazzotta G; Gallai V
J Sleep Res; 2003 Dec; 12(4):305-11. PubMed ID: 14633242
[TBL] [Abstract][Full Text] [Related]
18. Obesity and obstructive sleep apnea syndrome.
Acıoğlu E; Yiğit O; Volkan Sunter A; Taşkın U; Berçik İnal B; Sahin M
J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):744-51. PubMed ID: 21144373
[TBL] [Abstract][Full Text] [Related]
19. Association of sleep apnea severity and obesity with insulin resistance, C-reactive protein, and leptin levels in male patients with obstructive sleep apnea.
Kapsimalis F; Varouchakis G; Manousaki A; Daskas S; Nikita D; Kryger M; Gourgoulianis K
Lung; 2008; 186(4):209-217. PubMed ID: 18365276
[TBL] [Abstract][Full Text] [Related]
20. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.
Ryan S; Taylor CT; McNicholas WT
Am J Respir Crit Care Med; 2006 Oct; 174(7):824-30. PubMed ID: 16840748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
